Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner Purchases 358,619 Shares

Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner acquired 358,619 shares of the business’s stock in a transaction dated Wednesday, November 13th. The stock was purchased at an average price of $13.74 per share, with a total value of $4,927,425.06. Following the acquisition, the insider now owns 5,810,700 shares of the company’s stock, valued at approximately $79,839,018. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Joshua Kushner also recently made the following trade(s):

• On Monday, November 11th, Joshua Kushner bought 276,040 shares of Oscar Health stock. The stock was purchased at an average cost of $13.58 per share, for a total transaction of $3,748,623.20.

Oscar Health Trading Down 0.6 %

Shares of NYSE:OSCR opened at $13.48 on Thursday. The company has a current ratio of 0.73, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $3.26 billion, a PE ratio of -224.63, a P/E/G ratio of 12.49 and a beta of 1.67. Oscar Health, Inc. has a 1 year low of $6.93 and a 1 year high of $23.79. The firm has a fifty day moving average price of $18.28 and a 200 day moving average price of $18.30.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter last year, the company posted ($0.29) EPS. The business’s revenue was up 68.3% compared to the same quarter last year. Analysts expect that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Institutional Trading of Oscar Health

Several large investors have recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC increased its position in Oscar Health by 7.5% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock worth $255,000 after buying an additional 844 shares during the period. American International Group Inc. lifted its stake in shares of Oscar Health by 1.3% in the first quarter. American International Group Inc. now owns 79,411 shares of the company’s stock valued at $1,181,000 after buying an additional 1,009 shares during the period. Summit Trail Advisors LLC grew its position in Oscar Health by 5.4% during the second quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock worth $329,000 after buying an additional 1,065 shares in the last quarter. KBC Group NV increased its stake in Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after acquiring an additional 1,328 shares during the period. Finally, Arizona State Retirement System raised its holdings in Oscar Health by 3.7% in the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after acquiring an additional 1,351 shares in the last quarter. 75.70% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently commented on OSCR shares. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group initiated coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price for the company. Finally, Piper Sandler reissued an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $22.93.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.